{
    "nctId": "NCT05447949",
    "briefTitle": "Dexmedetomidine Versus Dexamethasone as Adjuncts in Erector Spinae Plane Block in Modified Radical Mastectomy",
    "officialTitle": "Comparison of Dexmedetomidine Versus Dexamethasone as Adjuncts to Levobupivacaine in Ultrasound Guided Erector Spinae Plane Block for Patients Undergoing Modified Radical Mastectomy, Randomized Double-Blinded Comparative Study.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Post Operative Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "Total amount of morphine consumed postoperatively for 24 hours.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Type of surgery; Modified Radical Mastectomy (MRM)\n* Physical status ASA II, III.\n* Age \u2265 18 and \u2264 65 Years.\n* Body mass index (BMI): \\> 20 kg/m2 and \\< 35 kg/m2.\n\nExclusion Criteria:\n\n* Patient's refusal\n* Age \\<18 years or \\>65 years\n* BMI \\<20 kg/m2 and \\>35 kg/m2\n* Known sensitivity or contraindication to drug used in the study (local anaesthetics, opioids).\n* History of psychological disorders and/or chronic pain.\n* Contraindication to regional anaesthesia e.g. local sepsis, pre- existing peripheral neuropathies and coagulopathy.\n* Severe respiratory or cardiac disorders.\n* Advanced liver or kidney disease. Pregnancy.\n* Physical status ASA IV.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}